Ryan Gill, CEO, Codebreaker
Ryan T. Gill, PhD is the CEO of Codebreaker, a company focused on bringing the biological ground truth to AI by programming biology to predict health. A scientific and entrepreneurial leader at the forefront of genome engineering and machine learning, Gill has built a career advancing technologies that generate high-dimensional biological data and applying AI-driven approaches to enable functional mapping and phenotype definition. He has founded and led as CEO/CSO multiple transformative biotech ventures—including Inscripta and Artisan Bio—and has established deep collaborations and research partnerships with major international companies (Takeda, Shell, DuPont, Novozymes) and institutions (NIH, NSF, DOE, DOD). Gill previously served as a named Professor at the University of Colorado and Danish Technical University, where he led world-class research programs in synthetic biology and high-throughput genome engineering that resulted in over 200 peer-reviewed publications and patents. Gill’s contributions have been recognized across both academia and industry, with honors that include keynote and invited speaking engagements at major scientific conferences, prestigious academic awards, and industry distinctions like “Company of the Year” and “Top 10 Innovation” for technologies he co-invented and brought to market.
